2023
DOI: 10.1016/j.xpro.2023.102104
|View full text |Cite
|
Sign up to set email alerts
|

An integrated workflow for phosphopeptide identification in natural killer cells (NK-92MI) and their targets (MDA-MB-231) during immunological synapse formation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…Furthermore, unlike microtubule-targeting drugs that exhibit a preference for selectively impairing rapidly dividing cancer cells and have demonstrated efficacy in treating various malignancies, actin-targeting drugs result in unacceptable levels of toxicity precluding their clinical utility. The identification of relevant molecular targets will require a thorough dissection of the cancer cell side of the IS and the development of innovative methodologies that can distinguish between the pre- and post-synaptic sides of the IS ( 170 ).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, unlike microtubule-targeting drugs that exhibit a preference for selectively impairing rapidly dividing cancer cells and have demonstrated efficacy in treating various malignancies, actin-targeting drugs result in unacceptable levels of toxicity precluding their clinical utility. The identification of relevant molecular targets will require a thorough dissection of the cancer cell side of the IS and the development of innovative methodologies that can distinguish between the pre- and post-synaptic sides of the IS ( 170 ).…”
Section: Discussionmentioning
confidence: 99%